Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)

ClinicalTrials.gov ID: NCT00236041

Public ClinicalTrials.gov record NCT00236041. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Comparison Study to Evaluate the Efficacy and Safety of ACTIQ® (Oral Transmucosal Fentanyl Citrate [OTFC®]) Treatment for Opioid-Tolerant Children and Adolescents With Breakthrough Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to evaluate the efficacy of ACTIQ treatment for the management of breakthrough pain (BTP) compared to placebo treatment in children with cancer and non-cancer pain who are receiving around-the-clock (ATC) opioid therapy and who require additional therapy for BTP episodes. This will be determined by the analysis of the pain intensity (PI), measured by the Faces Pain Scale-Revised (FPS-R) administered 15 minutes after the start of each unit of study drug with an optimal ACTIQ dosage.

Study identification

NCT ID
NCT00236041
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cephalon
Industry
Enrollment
38 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
3 Years to 15 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2004 (Type not available)
Primary completion
Not listed
Completion
Aug 2006 (Type not available)
Last update posted
May 9, 2014

2004 – 2006

United States locations

U.S. sites
30
U.S. states
21
U.S. cities
28
Facility City State ZIP Site status
Children's Hospital of Arkansas Little Rock Arkansas 72202 —
UCLA Pediatric Pain Program Los Angeles California 90095 —
Childrens Hospital of Orange Orange California 92868 —
Lucille Packard Childrens Hospital Palo Alto California 94304 —
Connecticut Childrens Medical Center Hartford Connecticut 06106 —
Children's National Medical Center Washington D.C. District of Columbia 20010 —
Nemours Childrens Clinic Jacksonville Florida 32207 —
St. Joseph's Children's Hospital Tampa Florida 33607 —
Scottish Rite Children's Medical Center Atlanta Georgia 30342 —
Kapi'olani Medical Center Honolulu Hawaii 96826 —
Children's Memorial Center Chicago Illinois 60614 —
Children's Memorial Hospital Chicago Illinois 60614 —
University Hospitals of Iowa Iowa City Iowa 52242 —
Cardinal Glennon Children's Hospital St Louis Missouri 63104 —
Hackensack University Medical Center Hackensack New Jersey 07601 —
Cancer Institute of New Jersey New Brunswick New Jersey 08901 —
University of New Mexico Albuquerque New Mexico 87131 —
SUNY Upstate Medical University Syracuse New York 13210 —
Children's Hospital at Montefiore The Bronx New York 10467 —
Duke University Hospital Durham North Carolina 27710 —
Akron Children's Hospital Akron Ohio 44308 —
Tod Children's Hospital Youngstown Ohio 44501 —
Milton S Hershey Medical Center Hershey Pennsylvania 17033 —
St. Christopher's Hospital for Children Philadelphia Pennsylvania 19134 —
Vanderbilt University Medical Nashville Tennessee 37232 —
Children's Cancer and Blood Disorders Center San Antonio Texas 78207 —
Methodist Hospital San Antonio Texas 78229 —
Sacred Heart Medical Center Spokane Washington 99204 —
West Virginia University Morgantown West Virginia 99204 —
Childrens Hospital of Wisconsin Milwaukee Wisconsin 53201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00236041, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2014 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00236041 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →